Determining risk factors for mortality in liver transplant patients with COVID-19
We continue to wish everyone working to fight COVID-19 well and we welcome you to this combined update from our two collaborating international registries: SECURE-Cirrhosis covering The Americas, China/Japan/Korea and COVID-Hep covering the rest of the world in an attempt to collate clinical details of patients with chronic liver disease who develop COVID-19.
Submissions to date: 205 cases, 123 (60%) men, median age of 61 years (IQR 48-69).